nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC7A11—tongue—salivary gland cancer	0.029	0.105	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—salivary gland cancer	0.0195	0.0706	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—salivary gland cancer	0.0163	0.059	CbGeAlD
Sulfasalazine—CHUK—connective tissue—salivary gland cancer	0.0145	0.0526	CbGeAlD
Sulfasalazine—CHUK—epithelium—salivary gland cancer	0.0138	0.05	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—salivary gland cancer	0.0136	0.0495	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—salivary gland cancer	0.0129	0.047	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—salivary gland cancer	0.0119	0.0432	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—salivary gland cancer	0.0106	0.0385	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—salivary gland cancer	0.0106	0.0385	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—salivary gland cancer	0.00985	0.0358	CbGeAlD
Sulfasalazine—PPARG—neck—salivary gland cancer	0.00855	0.0311	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—salivary gland cancer	0.00816	0.0296	CbGeAlD
Sulfasalazine—ACAT1—lymph node—salivary gland cancer	0.00802	0.0291	CbGeAlD
Sulfasalazine—IKBKB—lymphoid tissue—salivary gland cancer	0.0072	0.0262	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—salivary gland cancer	0.00671	0.0244	CbGeAlD
Sulfasalazine—PPARG—connective tissue—salivary gland cancer	0.00613	0.0223	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—salivary gland cancer	0.00598	0.0217	CbGeAlD
Sulfasalazine—CHUK—lymph node—salivary gland cancer	0.00598	0.0217	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—salivary gland cancer	0.00597	0.0217	CbGeAlD
Sulfasalazine—PPARG—epithelium—salivary gland cancer	0.00582	0.0211	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—salivary gland cancer	0.00448	0.0163	CbGeAlD
Sulfasalazine—ABCG2—parotid gland—salivary gland cancer	0.00446	0.0162	CbGeAlD
Sulfasalazine—ABCG2—saliva-secreting gland—salivary gland cancer	0.00428	0.0155	CbGeAlD
Sulfasalazine—IKBKB—lymph node—salivary gland cancer	0.00406	0.0148	CbGeAlD
Sulfasalazine—ALOX5—lymph node—salivary gland cancer	0.00337	0.0122	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—salivary gland cancer	0.00328	0.0119	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—salivary gland cancer	0.00313	0.0114	CbGeAlD
Sulfasalazine—PTGS1—epithelium—salivary gland cancer	0.00311	0.0113	CbGeAlD
Sulfasalazine—PTGS2—epithelium—salivary gland cancer	0.00297	0.0108	CbGeAlD
Sulfasalazine—PPARG—lymph node—salivary gland cancer	0.00253	0.00918	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—salivary gland cancer	0.00229	0.00832	CbGeAlD
Sulfasalazine—ABCC2—lymph node—salivary gland cancer	0.00222	0.00807	CbGeAlD
Sulfasalazine—ABCG2—lymph node—salivary gland cancer	0.00162	0.00589	CbGeAlD
Sulfasalazine—PTGS1—lymph node—salivary gland cancer	0.00135	0.00491	CbGeAlD
Sulfasalazine—PTGS2—lymph node—salivary gland cancer	0.00129	0.00469	CbGeAlD
Sulfasalazine—CHUK—Signaling by FGFR—HRAS—salivary gland cancer	0.000224	0.00031	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—PIK3CA—salivary gland cancer	0.000224	0.000309	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—HRAS—salivary gland cancer	0.000224	0.000309	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—HRAS—salivary gland cancer	0.000223	0.000308	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000223	0.000308	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—HRAS—salivary gland cancer	0.000222	0.000307	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—PIK3CA—salivary gland cancer	0.000222	0.000307	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	0.000222	0.000306	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MC3R—salivary gland cancer	0.000221	0.000306	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—PIK3CA—salivary gland cancer	0.000221	0.000305	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000219	0.000302	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAML2—salivary gland cancer	0.000219	0.000302	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ST3GAL4—salivary gland cancer	0.000218	0.000301	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—PTEN—salivary gland cancer	0.000218	0.000301	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PHGDH—salivary gland cancer	0.000218	0.000301	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000217	0.000299	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NUP62—salivary gland cancer	0.000216	0.000298	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000216	0.000298	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—salivary gland cancer	0.000215	0.000296	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.000214	0.000296	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AQP1—salivary gland cancer	0.000214	0.000296	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—VCAN—salivary gland cancer	0.000214	0.000295	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—DTX4—salivary gland cancer	0.000213	0.000295	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000213	0.000294	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MAP2K2—salivary gland cancer	0.000213	0.000294	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000213	0.000293	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PYGB—salivary gland cancer	0.000212	0.000293	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—salivary gland cancer	0.00021	0.00029	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—CREBBP—salivary gland cancer	0.00021	0.00029	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ST3GAL4—salivary gland cancer	0.00021	0.00029	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—PIK3CA—salivary gland cancer	0.000209	0.000289	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—PIK3CA—salivary gland cancer	0.000209	0.000289	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HRAS—salivary gland cancer	0.000209	0.000289	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—HRAS—salivary gland cancer	0.000209	0.000289	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.000209	0.000289	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—HRAS—salivary gland cancer	0.000207	0.000286	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—salivary gland cancer	0.000207	0.000285	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000207	0.000285	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000206	0.000284	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—HRAS—salivary gland cancer	0.000206	0.000284	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	0.000205	0.000283	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	0.000205	0.000283	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—HRAS—salivary gland cancer	0.000204	0.000282	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—salivary gland cancer	0.000202	0.000279	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FGFR4—salivary gland cancer	0.000202	0.000278	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	0.0002	0.000276	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.000199	0.000275	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ST3GAL4—salivary gland cancer	0.000199	0.000274	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—salivary gland cancer	0.000199	0.000274	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FBXW7—salivary gland cancer	0.000198	0.000274	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AQP1—salivary gland cancer	0.000198	0.000274	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—PTEN—salivary gland cancer	0.000198	0.000273	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTEN—salivary gland cancer	0.000195	0.000269	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—DTX4—salivary gland cancer	0.000194	0.000267	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—HRAS—salivary gland cancer	0.000194	0.000267	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—HRAS—salivary gland cancer	0.000194	0.000267	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—CREBBP—salivary gland cancer	0.000191	0.000263	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AQP1—salivary gland cancer	0.00019	0.000263	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—PIK3CA—salivary gland cancer	0.00019	0.000262	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	0.00019	0.000262	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000188	0.000259	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—JAG1—salivary gland cancer	0.000187	0.000258	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTEN—salivary gland cancer	0.000187	0.000257	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FGFR4—salivary gland cancer	0.000186	0.000257	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EP300—salivary gland cancer	0.000186	0.000256	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	0.000185	0.000256	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000185	0.000255	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FBXW7—salivary gland cancer	0.000183	0.000253	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FGFR4—salivary gland cancer	0.000183	0.000252	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—DTX4—salivary gland cancer	0.000181	0.000249	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FBXW7—salivary gland cancer	0.00018	0.000248	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—salivary gland cancer	0.000179	0.000247	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000179	0.000246	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—EP300—salivary gland cancer	0.000178	0.000246	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGF16—salivary gland cancer	0.000177	0.000244	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—salivary gland cancer	0.000175	0.000242	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CREBBP—salivary gland cancer	0.000174	0.000241	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PIK3CA—salivary gland cancer	0.000174	0.00024	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PHGDH—salivary gland cancer	0.000173	0.000239	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00017	0.000235	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NUP62—salivary gland cancer	0.00017	0.000234	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—VCAN—salivary gland cancer	0.000168	0.000232	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—FOXO3—salivary gland cancer	0.000167	0.000231	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ST3GAL4—salivary gland cancer	0.000167	0.00023	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDH1—salivary gland cancer	0.000166	0.000229	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTEN—salivary gland cancer	0.000163	0.000225	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000163	0.000224	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF16—salivary gland cancer	0.00016	0.000221	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CREBBP—salivary gland cancer	0.000158	0.000218	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NUP62—salivary gland cancer	0.000157	0.000217	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000157	0.000216	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.000156	0.000216	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—VCAN—salivary gland cancer	0.000156	0.000215	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—EP300—salivary gland cancer	0.000156	0.000215	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—FOXO3—salivary gland cancer	0.000155	0.000213	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—PIK3CA—salivary gland cancer	0.000154	0.000212	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAML2—salivary gland cancer	0.000153	0.000212	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000153	0.000211	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—FOXO3—salivary gland cancer	0.000152	0.000209	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AQP1—salivary gland cancer	0.000151	0.000209	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NUP62—salivary gland cancer	0.000151	0.000208	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDH1—salivary gland cancer	0.000151	0.000208	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—VCAN—salivary gland cancer	0.00015	0.000207	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00015	0.000207	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF16—salivary gland cancer	0.000149	0.000206	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000148	0.000204	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000145	0.0002	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NUP62—salivary gland cancer	0.000143	0.000198	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EP300—salivary gland cancer	0.000143	0.000198	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—salivary gland cancer	0.000142	0.000197	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—VCAN—salivary gland cancer	0.000142	0.000196	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.000142	0.000196	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	0.000142	0.000196	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000141	0.000194	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—PIK3CA—salivary gland cancer	0.00014	0.000193	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAML2—salivary gland cancer	0.000139	0.000192	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PIK3CA—salivary gland cancer	0.000137	0.00019	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAP2K2—salivary gland cancer	0.000137	0.000189	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTEN—salivary gland cancer	0.000136	0.000188	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—CREBBP—salivary gland cancer	0.000135	0.000186	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000134	0.000185	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PIK3CA—salivary gland cancer	0.000132	0.000182	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000132	0.000182	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	0.000131	0.000181	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JAG1—salivary gland cancer	0.000131	0.000181	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGFR4—salivary gland cancer	0.00013	0.00018	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.00013	0.00018	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—EP300—salivary gland cancer	0.00013	0.000179	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAML2—salivary gland cancer	0.00013	0.000179	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—salivary gland cancer	0.000129	0.000178	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FBXW7—salivary gland cancer	0.000128	0.000177	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000128	0.000176	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—salivary gland cancer	0.000127	0.000175	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAP2K2—salivary gland cancer	0.000126	0.000174	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000126	0.000174	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PTEN—salivary gland cancer	0.000124	0.000172	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAP2K2—salivary gland cancer	0.000124	0.000171	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000122	0.000168	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NUP62—salivary gland cancer	0.00012	0.000165	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PTEN—salivary gland cancer	0.00012	0.000165	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—VCAN—salivary gland cancer	0.000119	0.000164	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JAG1—salivary gland cancer	0.000119	0.000164	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EP300—salivary gland cancer	0.000119	0.000164	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—NOTCH1—salivary gland cancer	0.000119	0.000164	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGFR4—salivary gland cancer	0.000118	0.000163	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FBXW7—salivary gland cancer	0.000116	0.000161	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PIK3CA—salivary gland cancer	0.000115	0.000159	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PTEN—salivary gland cancer	0.000113	0.000156	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000113	0.000155	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000112	0.000154	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JAG1—salivary gland cancer	0.000111	0.000153	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGFR4—salivary gland cancer	0.00011	0.000152	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FBXW7—salivary gland cancer	0.000109	0.00015	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PTEN—salivary gland cancer	0.000108	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FOXO3—salivary gland cancer	0.000108	0.000149	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EP300—salivary gland cancer	0.000108	0.000149	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—CREBBP—salivary gland cancer	0.000108	0.000148	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000106	0.000146	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000104	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOTCH1—salivary gland cancer	0.000103	0.000143	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CREBBP—salivary gland cancer	0.000102	0.00014	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDH1—salivary gland cancer	0.000101	0.000139	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000101	0.000139	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FOXO3—salivary gland cancer	9.81e-05	0.000135	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—salivary gland cancer	9.8e-05	0.000135	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTEN—salivary gland cancer	9.65e-05	0.000133	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PIK3CA—salivary gland cancer	9.6e-05	0.000132	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	9.46e-05	0.000131	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	9.39e-05	0.00013	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CREBBP—salivary gland cancer	9.37e-05	0.000129	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CREBBP—salivary gland cancer	9.21e-05	0.000127	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—EP300—salivary gland cancer	9.2e-05	0.000127	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FOXO3—salivary gland cancer	9.15e-05	0.000126	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDH1—salivary gland cancer	9.14e-05	0.000126	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	8.96e-05	0.000124	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAP2K2—salivary gland cancer	8.84e-05	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PIK3CA—salivary gland cancer	8.78e-05	0.000121	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PIK3CA—salivary gland cancer	8.43e-05	0.000116	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CREBBP—salivary gland cancer	8.36e-05	0.000115	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—salivary gland cancer	8.12e-05	0.000112	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAP2K2—salivary gland cancer	8.01e-05	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PIK3CA—salivary gland cancer	7.96e-05	0.00011	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—salivary gland cancer	7.8e-05	0.000108	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PIK3CA—salivary gland cancer	7.65e-05	0.000106	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAP2K2—salivary gland cancer	7.47e-05	0.000103	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	7.46e-05	0.000103	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.45e-05	0.000103	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—salivary gland cancer	7.37e-05	0.000102	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—salivary gland cancer	7.25e-05	0.0001	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOTCH1—salivary gland cancer	7.24e-05	9.99e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	7.11e-05	9.81e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—salivary gland cancer	7.07e-05	9.76e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EP300—salivary gland cancer	6.91e-05	9.54e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—salivary gland cancer	6.81e-05	9.39e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—salivary gland cancer	6.69e-05	9.24e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	6.63e-05	9.14e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CREBBP—salivary gland cancer	6.58e-05	9.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—salivary gland cancer	6.57e-05	9.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOTCH1—salivary gland cancer	6.56e-05	9.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREBBP—salivary gland cancer	6.56e-05	9.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EP300—salivary gland cancer	6.38e-05	8.81e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EP300—salivary gland cancer	6.27e-05	8.65e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOTCH1—salivary gland cancer	6.12e-05	8.45e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CREBBP—salivary gland cancer	6.1e-05	8.41e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—salivary gland cancer	5.97e-05	8.24e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREBBP—salivary gland cancer	5.95e-05	8.21e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CREBBP—salivary gland cancer	5.86e-05	8.08e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—EP300—salivary gland cancer	5.69e-05	7.86e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREBBP—salivary gland cancer	5.55e-05	7.66e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	5.26e-05	7.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—salivary gland cancer	5.11e-05	7.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—salivary gland cancer	4.86e-05	6.7e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—salivary gland cancer	4.73e-05	6.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—salivary gland cancer	4.72e-05	6.52e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—salivary gland cancer	4.7e-05	6.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—salivary gland cancer	4.69e-05	6.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CREBBP—salivary gland cancer	4.65e-05	6.42e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—salivary gland cancer	4.64e-05	6.4e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—EP300—salivary gland cancer	4.48e-05	6.19e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EP300—salivary gland cancer	4.47e-05	6.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—salivary gland cancer	4.4e-05	6.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—salivary gland cancer	4.37e-05	6.03e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CREBBP—salivary gland cancer	4.37e-05	6.03e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—salivary gland cancer	4.35e-05	6.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—salivary gland cancer	4.29e-05	5.92e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—salivary gland cancer	4.25e-05	5.87e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—salivary gland cancer	4.21e-05	5.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—salivary gland cancer	4.18e-05	5.77e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—EP300—salivary gland cancer	4.15e-05	5.73e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EP300—salivary gland cancer	4.05e-05	5.59e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—EP300—salivary gland cancer	3.99e-05	5.51e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—salivary gland cancer	3.97e-05	5.47e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EP300—salivary gland cancer	3.78e-05	5.22e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—salivary gland cancer	3.32e-05	4.58e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—salivary gland cancer	3.32e-05	4.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—salivary gland cancer	3.31e-05	4.56e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—salivary gland cancer	3.2e-05	4.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—EP300—salivary gland cancer	3.17e-05	4.37e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—salivary gland cancer	3.12e-05	4.31e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—salivary gland cancer	3.07e-05	4.24e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—salivary gland cancer	3.06e-05	4.22e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—salivary gland cancer	3e-05	4.14e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—EP300—salivary gland cancer	2.98e-05	4.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—salivary gland cancer	2.95e-05	4.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—salivary gland cancer	2.9e-05	4e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—salivary gland cancer	2.8e-05	3.86e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—salivary gland cancer	2.77e-05	3.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—salivary gland cancer	2.59e-05	3.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—salivary gland cancer	2.34e-05	3.23e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	2.2e-05	3.04e-05	CbGpPWpGaD
